Alan Lada

Alan is our VP of Investor Relations.

He joins Oruka with more than a decade of experience in biopharma financial services, having most recently served as a VP of Equity Capital Markets at Guggenheim Partners, where he assisted companies in raising cumulative billions of dollars of capital. Prior to Guggenheim, he acted as an SVP and one of the leadership team members of Solebury Trout, the marquee investor relations firm formerly known as the Trout Group. During his time there, he managed investor relations strategy and execution for a number of public and private biopharma companies, ranging from preclinical to commercial stage. Additionally, he spent nine years in the US Army, between active duty and National Guard, and was honorably discharged as a Staff Sergeant after one tour in Afghanistan.

He received his BA, magna cum laude, from Maryville University, and studied political science at Rutgers College.